Rathbones Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,231
| Closed | -$3.95M | – | 434 |
|
|
2021
Q1 | $3.95M | Sell |
18,231
-11,774
| -39% | -$2.21M | 0.05% | 154 |
|
|
2020
Q4 | $3.46M | Sell |
30,005
-257
| -0.8% | -$28.8K | 0.05% | 155 |
|
|
2020
Q3 | $2.95M | Sell |
30,262
-915
| -3% | -$105K | 0.05% | 157 |
|
|
2020
Q2 | $3.83M | Sell |
31,177
-861
| -3% | -$97.7K | 0.08% | 128 |
|
|
2020
Q1 | $2.81M | Buy |
32,038
+5,356
| +20% | +$567K | 0.08% | 127 |
|
|
2019
Q4 | $2.79M | Buy |
26,682
+737
| +3% | +$82.6K | 0.07% | 133 |
|
|
2019
Q3 | $2.98M | Buy |
25,945
+1,970
| +8% | +$299K | 0.08% | 126 |
|
|
2019
Q2 | $4.13M | Buy |
23,975
+6,268
| +35% | +$1.08M | 0.13% | 107 |
|
|
2019
Q1 | $2.98M | Sell |
17,707
-1,403
| -7% | -$209K | 0.1% | 120 |
|
|
2018
Q4 | $1.86M | Buy |
19,110
+570
| +3% | +$74.8K | 0.07% | 136 |
|
|
2018
Q3 | $3.2M | Sell |
18,540
-5,706
| -24% | -$823K | 0.11% | 107 |
|
|
2018
Q2 | $3.38M | Sell |
24,246
-100
| -0.4% | -$14.2K | 0.13% | 104 |
|
|
2018
Q1 | $2.74M | Sell |
24,346
-1,905
| -7% | -$240K | 0.11% | 113 |
|
|
2017
Q4 | $3.46M | Sell |
26,251
-360
| -1% | -$42.3K | 0.14% | 102 |
|
|
2017
Q3 | $2.7M | Hold |
26,611
| – | – | 0.12% | 117 |
|
|
2017
Q2 | $2.67M | Sell |
26,611
-3,792
| -12% | -$408K | 0.12% | 120 |
|
|
2017
Q1 | $3.68M | Sell |
30,403
-291
| -0.9% | -$35.7K | 0.17% | 98 |
|
|
2016
Q4 | $3.43M | Buy |
+30,694
| New | +$3.69M | 0.17% | 95 |
|
Other funds holding GWPH
Rathbones Group's GWPH Position: Q2 2021 in Review
Rathbones Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 18,231 shares — an estimated $3.95M sold.
Rathbones Group first reported a position in GWPH in Q4 2016 and held it in 18 quarters. The position peaked at $4.13M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Rathbones Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Rathbones Group sold 18,231 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3.95M.
- Rathbones Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 18 quarters.
- Rathbones Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.13M in Q2 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Rathbones Group's 13F filing for Q2 2021, filed 30 Jul 2021.